Alcidion (ASX:ALC) — Material Events
ASX:ALC · 16 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Alcidion Surges with Record Q4 Cashflow and $73.8M in New SalesMedium
Alcidion posts record Q4 cashflow and sales, reaffirms FY25 EBITDA guidance above $4.5M
24 July 2025
·Quarterly Activities Report
·90
Alcidion’s FY25 Surge, $39M NHS Contract Fuels Record GrowthHigh
Alcidion posts record FY25 results with major NHS contract and strong growth outlook
28 Aug 2025
·Full Year Results & Annual Report
·90
Alcidion Eyes $35M UK EPR Deal Amid 40% Revenue Surge in Q2 FY26Medium
Alcidion secures $35M+ UK EPR contract, reports 40% revenue growth and strong cash position in Q2 FY26
15 Jan 2026
·Quarterly Activities Report and Appendix 4C
·85
Alcidion Posts 44% Revenue Surge and Profit Turnaround, Eyes $35M UK ContractHigh
Alcidion reports 44% revenue growth and profit turnaround in H1 FY26, secures major UK contract
26 Feb 2026
·Appendix 4D & Half-Year Financial Report
·85
Alcidion’s Record FY25 Boosts AI-Driven Healthcare ExpansionMedium
Alcidion posts record FY25 revenue and contracts, expands AI healthcare platform and global footprint
16 Oct 2025
·Annual General Meeting Address and Presentation
·85
Alcidion Reports $1.7M Q3 Cashflow, Eyes May Signing for $35M UK EPR DealMedium
Alcidion posts positive Q3 FY26 cashflow and sales, reconfirms FY26 guidance with strong contract pipeline
29 Apr 2026
·Quarterly Activities Report and Appendix 4C
·85
Alcidion Secures $73.8M in Contracts, Posts Record FY25 Revenue and EBITDAHigh
Alcidion posts record FY25 revenue and EBITDA, secures $73.8M contracts including $39M UK EPR deal
28 Aug 2025
·FY Results Presentation
·85
Alcidion Unlocks AI Medical Device Sales with Dual AU-UK ApprovalMedium
Alcidion obtains dual AU and UK medical device registration for AI clinical tool, enabling commercial rollout
19 Feb 2026
·Regulatory Approval Announcement
·85
Alcidion Secures $35M UK EPR Contract with University Hospitals SussexMedium
Alcidion secures $35M 7-year EPR contract with University Hospitals Sussex
25 May 2026
·Major Contract Announcement
·85
Alcidion Boosts FY26 Outlook with $8.2M Q1 Sales and Cash Flow TurnaroundMedium
Alcidion posts strong Q1 FY26 sales and cash flow improvement, reconfirms positive FY26 guidance
28 Oct 2025
·Quarterly Activities Report and Appendix 4C
·80
Alcidion Expands Australian Patient Flow Footprint with $3M Kyra AcquisitionMedium
Alcidion acquires Kyra flow products from Telstra Health in $3M deal to expand patient flow solutions
18 May 2026
·Acquisition Announcement
·80
Alcidion Reaffirms FY26 Targets as Kyra Acquisition Boosts Patient Flow ReachMedium
Alcidion reconfirms FY26 guidance and completes Kyra flow products acquisition
29 June 2026
·Trading Update and Acquisition Completion
·80
Alcidion Secures Major EPR Deal with University Hospitals SussexMedium
Alcidion chosen as preferred EPR supplier by University Hospitals Sussex with contract valued over A$35M
8 Jan 2026
·Contract Award Announcement
·80
Alcidion Secures $12.3M Contract Boost with Leidos AustraliaMedium
Alcidion expands $12.3M contract with Leidos Australia, boosting ARR by $2.5M
17 Nov 2025
·Contract Expansion
·75
Alcidion Rebounds to $1.65M Profit on 10% Revenue Boost and Cost CutsMedium
Alcidion Group posts $1.65M profit in FY25, reversing prior year loss with 10% revenue growth and cost cuts
28 Aug 2025
·Appendix 4E - Preliminary Final Report
·Unexpected
·75
No articles in this tier for the last 12 months.
Market Mentions
5
- appeared in market wrap coverage
These are market wrap articles where Alcidion (ASX:ALC) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 27 (29 June -> 3 July) 2026
4 July 2026
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026
Market Wrap - Week 3 (12 Jan -> 16 Jan) 2026
18 Jan 2026